Adlai Competitors
| ANL Stock | 10.01 0.13 1.28% |
Adlai Nortye vs SeaStar Medical Correlation
Very good diversification
The correlation between Adlai Nortye Ltd and ICU is -0.29 (i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Adlai Nortye Ltd and ICU in the same portfolio, assuming nothing else is changed.
Moving against Adlai Stock
| 0.71 | ABP | Abpro Holdings | PairCorr |
| 0.64 | KURA | Kura Oncology | PairCorr |
| 0.54 | LYRA | Lyra Therapeutics | PairCorr |
| 0.5 | DWTX | Dogwood Therapeutics | PairCorr |
| 0.43 | GNLX | Genelux Common | PairCorr |
Adlai Nortye Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Adlai Nortye and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Adlai and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Adlai Nortye does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Adlai Stock performing well and Adlai Nortye Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Adlai Nortye's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| GOVX | 5.30 | (2.32) | 0.00 | (0.86) | 0.00 | 9.38 | 42.89 | |||
| BLRX | 2.56 | (0.26) | 0.00 | (0.22) | 0.00 | 5.20 | 13.04 | |||
| THAR | 5.53 | 0.62 | 0.10 | 0.50 | 5.92 | 11.55 | 35.56 | |||
| ADAP | 12.64 | 0.55 | 0.04 | 0.50 | 15.04 | 22.82 | 168.52 | |||
| APLM | 6.17 | 0.71 | 0.10 | 0.87 | 6.61 | 17.08 | 44.38 | |||
| AIMD | 4.53 | (0.71) | 0.00 | (0.17) | 0.00 | 12.30 | 38.73 | |||
| OSRH | 6.26 | (0.23) | 0.00 | (0.05) | 0.00 | 15.25 | 43.23 | |||
| LPCN | 4.89 | 1.85 | 0.37 | (2.81) | 3.30 | 15.95 | 33.09 | |||
| ADTX | 10.03 | (2.67) | 0.00 | (2.76) | 0.00 | 22.54 | 63.67 | |||
| ICU | 4.97 | (1.14) | 0.00 | (0.48) | 0.00 | 9.58 | 34.66 |
Cross Equities Net Income Analysis
Compare Adlai Nortye and related stocks such as GeoVax Labs, BioLineRx, and Tharimmune Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GOVX | 36.7 M | (2.3 M) | (2.1 M) | (2.3 M) | (2.7 M) | (2.7 M) | (3.3 M) | (2.2 M) | (2.6 M) | (2.4 M) | (2.9 M) | (18.5 M) | (14 M) | (26 M) | (25 M) | (22.5 M) | (21.4 M) |
| BLRX | (32.1 M) | (13.2 M) | (20.4 M) | (17.6 M) | (10.2 M) | (14.4 M) | (15.8 M) | (24.4 M) | (23 M) | (25.4 M) | (30 M) | (27.1 M) | (25 M) | (60.6 M) | (9.2 M) | (8.3 M) | (8.7 M) |
| THAR | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | (2.4 M) | (2.2 M) | (8.5 M) | (9.3 M) | (12.2 M) | (11 M) | (10.4 M) |
| APLM | (45.9 M) | (45.9 M) | (45.9 M) | (45.9 M) | (45.9 M) | (45.9 M) | (45.9 M) | (45.9 M) | (45.9 M) | (45.9 M) | (74.8 M) | (94.8 M) | (240.8 M) | (172.6 M) | (53.9 M) | (48.5 M) | (50.9 M) |
| AIMD | (300 K) | (1.3 M) | (650.8 K) | (622.6 K) | (622.6 K) | (521.9 K) | (670 K) | (617.4 K) | (1.3 M) | (1.6 M) | (1.5 M) | (3.9 M) | (14 M) | (13.8 M) | (14.9 M) | (13.4 M) | (12.7 M) |
| OSRH | (23.8 K) | (23.8 K) | (23.8 K) | (23.8 K) | (23.8 K) | (23.8 K) | (23.8 K) | (23.8 K) | (23.8 K) | (23.8 K) | (23.8 K) | (3.3 K) | (35.4 K) | 403.8 K | (2.4 M) | (2.2 M) | (2.1 M) |
| LPCN | (5.2 K) | (5.2 K) | (76.7 K) | (10.6 M) | (20.4 M) | (18.2 M) | (19 M) | (21 M) | (11.7 M) | (13 M) | (21 M) | (634.4 K) | (10.8 M) | (16.4 M) | 8.4 K | 7.5 K | 7.9 K |
| ADTX | (213 K) | (213 K) | (213 K) | (213 K) | (213 K) | (213 K) | (213 K) | (213 K) | (5.7 M) | (5.8 M) | (9.1 M) | (46.4 M) | (27.6 M) | (32.4 M) | (34.4 M) | (31 M) | (32.6 M) |
| ICU | (3.3 M) | (3.3 M) | (3.3 M) | (3.3 M) | (3.3 M) | (3.3 M) | (3.3 M) | (3.3 M) | (3.3 M) | (3.3 M) | (3.3 M) | (4.6 M) | (23 M) | (26.2 M) | (24.8 M) | (22.3 M) | (23.5 M) |
Adlai Nortye and related stocks such as GeoVax Labs, BioLineRx, and Tharimmune Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Adlai Nortye financial statement analysis. It represents the amount of money remaining after all of Adlai Nortye Ltd operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Adlai Nortye Competitive Analysis
The better you understand Adlai Nortye competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Adlai Nortye's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Adlai Nortye's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Adlai Nortye Competition Performance Charts
Five steps to successful analysis of Adlai Nortye Competition
Adlai Nortye's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Adlai Nortye in relation to its competition. Adlai Nortye's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Adlai Nortye in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Adlai Nortye's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Adlai Nortye, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Adlai Nortye position
In addition to having Adlai Nortye in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Millennials Best Thematic Idea Now
Millennials Best
Companies or funds that provide products or services that appeal to the generation of millennials and that are expected to experience growth in the next 5 years. The millennial generation usually refers to the demographic population that were born between 1980 to 2000. The Millennials Best theme has 77 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Millennials Best Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Adlai Nortye Correlation with its peers. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adlai Nortye. If investors know Adlai will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Adlai Nortye assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (1.19) | Revenue Per Share | Quarterly Revenue Growth 1.18 | Return On Assets | Return On Equity |
Understanding Adlai Nortye requires distinguishing between market price and book value, where the latter reflects Adlai's accounting equity. The concept of intrinsic value - what Adlai Nortye's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Adlai Nortye's price substantially above or below its fundamental value.
Understanding that Adlai Nortye's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Adlai Nortye represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Adlai Nortye's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.